Drug Device Combination Products Market Share 2021: Global Trends, Key Players, Industry Analysis Report to 2027

The Drug Device Combination Products Market size is expected to grow at an annual average of 10% during 2021-2027. A drug-device combination product is a medical device that consists of a medical device and an active pharmaceutical ingredient that are physically or chemically joined together as a “monolith”. These products lead to safer and more effective management and treatment of multiple disorders due to their precise drug delivery, topical administration and individual treatment. Featured drug-device combination products include drug-eluting stents, infusion pumps, inhalers, transdermal delivery systems, and prefilled syringes. This technologically advanced product is used to manage and treat a number of chronic conditions such as cancer, diabetes, respiratory problems, cardiovascular disease, wound healing, and more.

The following segmentation are covered in this report:

By End User

• Hospital & clinic
• Ambulatory surgery center (ASC)
• Home care setting
• Other end users

 By Wound Type

• Cardiovascular disease
• Diabetes
• Respiratory problem
• Cancer treatment
• Antimicrobial application
• Other applications

 Company Profile

• Abbott Laboratories
• Medtronic Plc
• Boston Scientific Corp
• Becton, Dickinson and Company
• Novartis AG
• GlaxoSmithKline plc
• Allergen, Inc.
• Stryker Corporation
• Terumo Corporation

Scope of the report

The research study analyses the Drug Device Combination Products Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Drug Device Combination Products Market Report

• What was the Drug Device Combination Products Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Drug Device Combination Products Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.